                         SEQUENCE LISTING

<110>  Etablissement Franais du Sang
       EL JAAFARI, Assia
       RIGAL, Dominique
       SCOTT, Diane
 
<120>  Epitope HLA-DR7 HY et mthode de traitement de la leucmie

<130>  BET12P2966

<150>  FR1160578
<151>  2011-11-21

<160>  33    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide TL15

<400>  1

Thr Gly Lys Ile Ile Asn Phe Ile Lys Phe Asp Thr Gly Asn Leu 
1               5                   10                  15  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide dcrit dans Ivanov et al, exclu de l'invention

<400>  2

Thr Ile Arg Tyr Pro Asp Pro Val Ile 
1               5                   


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide dcrit dans Spierings et al, exclu de l'invention

<400>  3

Val Ile Lys Val Asn Asp Thr Val Gln Ile 
1               5                   10  


<210>  4
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide QR-40

<400>  4

Gln Ile Asp Leu Gly Thr Gly Lys Ile Ile Asn Phe Ile Lys Phe Asp 
1               5                   10                  15      


Thr Gly Asn Leu Cys Met Val Ile Gly Gly Ala Asn Leu Gly Arg Val 
            20                  25                  30          


Gly Val Ile Thr Asn Arg Glu Arg 
        35                  40  


<210>  5
<211>  263
<212>  PRT
<213>  Homo sapiens

<400>  5

Met Ala Arg Gly Pro Lys Lys His Leu Lys Arg Val Ala Ala Pro Lys 
1               5                   10                  15      


His Trp Met Leu Asp Lys Leu Thr Gly Val Phe Ala Pro Arg Pro Ser 
            20                  25                  30          


Thr Gly Pro His Lys Leu Arg Glu Cys Leu Pro Leu Ile Val Phe Leu 
        35                  40                  45              


Arg Asn Arg Leu Lys Tyr Ala Leu Thr Gly Asp Glu Val Lys Lys Ile 
    50                  55                  60                  


Cys Met Gln Arg Phe Ile Lys Ile Asp Gly Lys Val Arg Val Asp Val 
65                  70                  75                  80  


Thr Tyr Pro Ala Gly Phe Met Asp Val Ile Ser Ile Glu Lys Thr Gly 
                85                  90                  95      


Glu His Phe Arg Leu Val Tyr Asp Thr Lys Gly Arg Phe Ala Val His 
            100                 105                 110         


Arg Ile Thr Val Glu Glu Ala Lys Tyr Lys Leu Cys Lys Val Arg Lys 
        115                 120                 125             


Ile Thr Val Gly Val Lys Gly Ile Pro His Leu Val Thr His Asp Ala 
    130                 135                 140                 


Arg Thr Ile Arg Tyr Pro Asp Pro Val Ile Lys Val Asn Asp Thr Val 
145                 150                 155                 160 


Gln Ile Asp Leu Gly Thr Gly Lys Ile Ile Asn Phe Ile Lys Phe Asp 
                165                 170                 175     


Thr Gly Asn Leu Cys Met Val Ile Gly Gly Ala Asn Leu Gly Arg Val 
            180                 185                 190         


Gly Val Ile Thr Asn Arg Glu Arg His Pro Gly Ser Phe Asp Val Val 
        195                 200                 205             


His Val Lys Asp Ala Asn Gly Asn Ser Phe Ala Thr Arg Leu Ser Asn 
    210                 215                 220                 


Ile Phe Val Ile Gly Asn Gly Asn Lys Pro Trp Ile Ser Leu Pro Arg 
225                 230                 235                 240 


Gly Lys Gly Ile Arg Leu Thr Val Ala Glu Glu Arg Asp Lys Arg Leu 
                245                 250                 255     


Ala Thr Lys Gln Ser Ser Gly 
            260             


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Premier fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  6

Thr Gly Lys Ile Ile Asn Phe Ile Lys 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Deuxime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  7

Gly Lys Ile Ile Asn Phe Ile Lys Phe 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Troisime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  8

Lys Ile Ile Asn Phe Ile Lys Phe Asp 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Quatrime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  9

Ile Ile Asn Phe Ile Lys Phe Asp Thr 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cinquime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  10

Ile Asn Phe Ile Lys Phe Asp Thr Gly 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Sixime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  11

Asn Phe Ile Lys Phe Asp Thr Gly Asn 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Septime fragment de 9 acides amins conscutifs de SEQ ID NO: 1

<400>  12

Phe Ile Lys Phe Asp Thr Gly Asn Leu 
1               5                   


<210>  13
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide SK-31

<400>  13

Ser Thr Gly Pro His Lys Leu Arg Glu Cys Leu Pro Leu Ile Val Phe 
1               5                   10                  15      


Leu Arg Asn Arg Leu Lys Tyr Ala Leu Thr Gly Asp Glu Val Lys 
            20                  25                  30      


<210>  14
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide KM-25

<400>  14

Lys Ile Cys Met Gln Arg Phe Ile Lys Ile Asp Gly Lys Val Arg Val 
1               5                   10                  15      


Asp Val Thr Tyr Pro Ala Gly Phe Met 
            20                  25  


<210>  15
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide DA-32

<400>  15

Asp Val Ile Ser Ile Glu Lys Thr Gly Glu His Phe Arg Leu Val Tyr 
1               5                   10                  15      


Asp Thr Lys Gly Arg Phe Ala Val His Arg Ile Thr Val Glu Glu Ala 
            20                  25                  30          


<210>  16
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide EV-44

<400>  16

Glu Glu Ala Lys Tyr Lys Leu Cys Lys Val Arg Lys Ile Thr Val Gly 
1               5                   10                  15      


Val Lys Gly Ile Pro His Leu Val Thr His Asp Ala Arg Thr Ile Arg 
            20                  25                  30          


Tyr Pro Asp Pro 
        35      


<210>  17
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Hotspot dont est issu le peptide SK-31

<400>  17

Glu Cys Leu Pro Leu Ile Val Phe Leu Arg Asn Arg Leu Lys Tyr Ala 
1               5                   10                  15      


Leu Thr Gly Asp Glu Val Lys Lys Ile Cys Met Gln Arg Phe Ile Lys 
            20                  25                  30          


Ile Asp Gly Lys Val Arg Val Asp Val Thr 
        35                  40          


<210>  18
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Net MHC dont est issu le peptide SK-31

<400>  18

Lys Leu Arg Glu Cys Leu Pro Leu Ile Val Phe Leu Arg Asn Arg Leu 
1               5                   10                  15      


Lys Tyr Ala Leu 
            20  


<210>  19
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Propred dont est issu le peptide SK-31

<400>  19

Leu Ile Val Phe Leu Arg Asn Arg Leu Lys Tyr Ala Leu 
1               5                   10              


<210>  20
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Hotspot dont est issu le peptide KM-25

<400>  20

Lys Ile Cys Met Gln Arg Phe Ile Lys Ile Asp Gly Lys Val Arg Val 
1               5                   10                  15      


Asp Val Thr 
            


<210>  21
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Hotspot dont est issu le peptide DA-32

<400>  21

Phe Arg Leu Val Tyr Asp Thr Lys Gly Arg Phe Ala Val His Arg Ile 
1               5                   10                  15      


Thr 
    


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Deuxime motif coeur de la base Hotspot dont est issu le peptide 
       DA-32

<400>  22

Thr Lys Gly Arg Phe Ala Val His Arg Ile Thr Val 
1               5                   10          


<210>  23
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Hotspot dont est issu le peptide EV-44

<400>  23

Lys Tyr Lys Leu Cys Lys Val Arg Lys Ile Thr Val Gly Val Lys Gly 
1               5                   10                  15      


<210>  24
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Net MHC dont est issu le peptide EV-44

<400>  24

Lys Tyr Lys Leu Cys Lys Val Arg Lys Ile Thr Val Gly Val Lys Gly 
1               5                   10                  15      


Ile Pro His 
            


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Propred dont est issu le peptide EV-44

<400>  25

Tyr Lys Leu Cys Lys Val Arg Lys Ile 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Deuxime motif coeur de la base Propred sont est issu le peptide 
       EV-44

<400>  26

Leu Val Thr His Asp Ala Arg Thr Ile 
1               5                   


<210>  27
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Hotspot dont est issu le peptide QR-40

<400>  27

Gly Lys Ile Ile Asn Phe Ile Lys Phe Asp Thr Gly Asn Leu Cys Met 
1               5                   10                  15      


<210>  28
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Deuxime motif coeur de la base Hotspot dont est issu le peptide 
       QR-40

<400>  28

Thr Gly Asn Val Cys Met Val Ile Ala Gly Ala Asn Leu Gly Arg Val 
1               5                   10                  15      


Gly 
    


<210>  29
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Net MHC dont est issu le peptide QR-40

<400>  29

Gly Gly Ala Asn Leu Gly Arg Val Gly Val 
1               5                   10  


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Motif coeur de la base Propred dont est issu le peptide QR-40

<400>  30

Phe Ile Lys Phe Asp Thr Gly Asn Leu 
1               5                   


<210>  31
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide GV17

<400>  31

Gly Lys Ile Ile Asn Phe Ile Lys Phe Asp Thr Gly Asn Leu Cys Met 
1               5                   10                  15      


Val 
    


<210>  32
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide TG17-1

<400>  32

Thr Gly Asn Leu Cys Met Val Ile Gly Gly Ala Asn Leu Gly Arg Val 
1               5                   10                  15      


Gly 
    


<210>  33
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide TG17-2

<400>  33

Thr Gly Asn Val Cys Met Val Ile Ala Gly Ala Asn Leu Gly Arg Val 
1               5                   10                  15      


Gly 
    


